A Multicenter Randomized Controlled Trial of Nevirapine Versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1
Dhayendre Moodley(University of KwaZulu-Natal), Maria Gigliotti(Boehringer Ingelheim (Germany)), James McIntyre(University of Namur), Patrick Robinson(Boehringer Ingelheim (Germany)), Lynette Boshoff(Mintek), Justus Hofmyer, Jagidesa Moodley(University of KwaZulu-Natal), David B. Hall(Boehringer Ingelheim (Germany)), John L. Sullivan, Hoosen Coovadia(University of KwaZulu-Natal), Glenda Gray(South African Medical Research Council), Cheryl Nikodem
Cited by 346
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa
|The Lancet|2004|1.3k
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
|Nature|2022|622
Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection
|Social Science & Medicine|2004|573
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|536